中东和非洲兽用疫苗市场预测至 2028 年 - COVID-19 影响和按疫苗类型划分的区域分析（牲畜疫苗 [牛疫苗和小型反刍动物疫苗]、伴侣动物疫苗 [猫疫苗、犬疫苗等] 等）和技术（减毒活疫苗、灭活疫苗、类毒素疫苗、重组疫苗、结合疫苗等）

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

No. of Pages: 125    |    Report Code: TIPRE00027167    |    Category: Life Sciences

Explore in Your Language
English Arabic French German Italian Korean Spanish Japanese
Middle East and Africa Veterinary Vaccines Market
Free Sample Buy Now

市场介绍

MEA由三个主要国家组成，即阿拉伯联合酋长国（UAE） 、沙特阿拉伯、南非和中东和非洲其他地区。沙特阿拉伯在 2020 年占据市场主导地位。沙特阿拉伯是中东和非洲增长最快的地区之一；其增长是由于该国动物相关公司越来越多地参与扩大其业务运营而推动的，这预计将支持该国市场的增长。例如：2020 年 4 月，总部位于该国的 Almarai 计划扩大其家禽相关业务。该公司投资额为 2.75 亿沙特里亚尔（7,330 万美元）。中东和非洲国家食源性疾病和人畜共患疾病发病率的上升推动了该国对动物健康的需求。例如，沙特阿拉伯的狂犬病仍然是一个公共卫生问题，狗和骆驼是主要的宿主，并继续给全国各地的人类和动物带来健康风险。此外，该国对膳食用动物性产品的需求不断增加，进一步推动了增长。例如，根据美国农业部 (USDA) 的数据，沙特阿拉伯 2019 年鸡肉产量预计为 73 万吨，2020 年预计将增至 75 万吨。今年鸡肉消费量预计为 133 万吨预计到 2020 年将达到 138 万吨。因此，上述因素预计将在预测期内推动沙特阿拉伯兽用疫苗市场的发展。

如果COVID-19、MEA 受到严重影响，尤其是南非。兽用疫苗的需求在一段时间内下降，直到病毒在动物中新的传播尚未得到证实。当该地区各地报告多只动物病毒检测呈阳性的病例时，多家涉足兽用疫苗的老牌制药公司加大了研发和生产力度，生产和开发针对 SARS-CoV 的疫苗和药物-2病毒。由于人畜共患疾病发病率上升，兽用疫苗的需求不断增加，但供应链和服务提供商无法满足需求，受到很大影响。一些国家出现了兽药供应中断和药品短缺的情况，这主要是由于生产基地的临时封锁、出口禁令以及治疗 COVID-19 的药品需求不断增长。各国政府采取措施缓解药品供应。例如，南非卫生产品监管局向负责兽药的公司发布了有关监管框架调整的指南，主要是为了应对这一大流行情况下面临的挑战。目前中东和北非地区各国的兽用疫苗市场差异很大。例如，沙特阿拉伯的高购买力和对昂贵外国品牌的文化偏好导致 85% 的药品都是进口的。

市场概况和动态

MEA兽用疫苗市场预计将从424.56美元增长 2021 年 100 万美元，到 2028 年将达到 5.9921 亿美元；预计 2021 年至 2028 年复合年增长率为 5.0%。根据世界卫生组织的数据，食源性疾病 (FBD) 是发病和死亡的主要原因之一。这些疾病可由多种化学污染物、细菌、病毒、寄生虫和生物毒素引起，通常被称为被忽视的疾病。 FBD 的传播及其影响是人类健康的主要问题。对动物产品的需求不断增长，加上人们对动物福利的认识不断提高，导致运营管理发生变化。与人类一样，宠物和农场动物也容易感染由细菌、病毒、真菌和寄生虫引起的许多疾病。因此，已经采用了多种技术，例如兽医疫苗接种。这些疫苗是在严格的监管环境下获得许可和生产的，以确保其安全性、有效性和质量。针对食源性寄生虫的兽用疫苗可通过减少动物感染来改善动物健康，并通过管理 FBD 的重要来源来帮助改善公共卫生。此外，疫苗还可以通过预防或减少某些传染病的危险来保护农场动物。健康的动物是健康饮食的基石；因此，免疫接种有助于保护动物食品。兽医专业为农民提供保护动物健康和福利所需的免疫接种。在畜牧业中，仅在保护动物健康所必需时才使用抗生素，意味着依靠非抗生素替代品来控制动物健康，并在需要抗生素时就抗生素选择和治疗程序做出最佳治疗决策。疫苗是强化抗生素的可能替代品。在最近对养猪生产中抗菌药物替代品进行的跨境专家评级中，疫苗接种按照感知可行性排名，并在感知功效方面名列前五名替代技术。因此，食源性疾病和感染患病率的上升预计将推动 MEA 市场的增长。

主要细分市场

从疫苗类型来看，牲畜疫苗占据MEA兽用疫苗市场最大份额2020年。从技术角度来看，减毒活疫苗细分市场在2020年MEA兽用疫苗市场中占有较大的市场份额。

主要来源和上市公司

准备本 MEA 兽用疫苗市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有BIOVAC；勃林格殷格翰国际有限公司；塞瓦；埃兰科；海丝特生物科学有限公司；海普拉；默克公司；纽根公司；维克；和硕腾公司等。

购买报告的理由

  • 了解 MEA 兽用疫苗市场格局并确定最有可能保证强劲回报的细分市场
  • < span>了解 MEA 兽用疫苗市场不断变化的竞争格局，保持领先地位
  • 通过识别细分市场，有效规划 MEA 兽用疫苗市场的并购和合作交易最有前途的可能销售
  • 通过对 MEA 兽用疫苗市场各个细分市场的市场表现进行敏锐而全面的分析，有助于做出明智的业务决策
    • < li>获取中东和非洲地区 2021-2028 年各细分市场的市场收入预测。

MEA 兽用疫苗市场细分

MEA 兽用疫苗市场 - 按疫苗类型

  • 牲畜疫苗
    • 牛疫苗
    • 小型反刍动物疫苗
  • 伴侣动物疫苗
    • 猫科动物疫苗
    • 犬疫苗
    • 其他
  • 其他

MEA 兽用疫苗市场 - 按

技术< /strong>

  • 减毒活疫苗
  • 灭活疫苗
  • 类毒素疫苗
  • 重组疫苗
  • 结合疫苗
  • 其他

MEA 兽用疫苗市场 - 按国家/地区

< ul>
  • 沙特阿拉伯
  • 南非
  • 阿联酋
    • < li>MEA 其余地区

    MEA 兽用疫苗市场 - 公司简介

    • BIOVAC
    • 勃林格殷格翰国际有限公司
    • Ceva < /span>
    • Elanco
    • Hester Biosciences Limited
    • HIPRA
    • 默克公司
    • NEOGEN Corporation
    • Virbac< /span>
    • 硕腾公司



    Middle East and Africa Veterinary Vaccines Strategic Insights

    Strategic insights for Middle East and Africa Veterinary Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/middle-east-and-africa-veterinary-vaccines-market-strategic-framework.webp
    Get more information on this report

    Middle East and Africa Veterinary Vaccines Report Scope

    Report Attribute Details
    Market size in 2021 US$ 424.56 Million
    Market Size by 2028 US$ 599.21 Million
    Global CAGR (2021 - 2028) 5.0%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By 疫苗类型
    • 牲畜疫苗
    • 伴侣动物疫苗
    By 技术
    • 减毒活疫苗
    • 灭活疫苗
    • 类毒素疫苗
    • 重组疫苗
    • 结合疫苗
    Regions and Countries Covered 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
    Market leaders and key company profiles
  • BIOVAC
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Elanco
  • Hester Biosciences Limited
  • HIPRA
  • Merck & Co., Inc.
  • NEOGEN Corporation
  • Virbac
  • Zoetis Inc.
    		•
    Get more information on this report

    Middle East and Africa Veterinary Vaccines Regional Insights

    The regional scope of Middle East and Africa Veterinary Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-veterinary-vaccines-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Middle East and Africa Veterinary Vaccines Market

    1. BIOVAC
    2. Boehringer Ingelheim International GmbH
    3. Ceva
    4. Elanco
    5. Hester Biosciences Limited
    6. HIPRA
    7. Merck & Co., Inc. 
    8. NEOGEN Corporation  
    9. Virbac  
    10. Zoetis Inc.
    Frequently Asked Questions
    How big is the Middle East and Africa Veterinary Vaccines Market?

    The Middle East and Africa Veterinary Vaccines Market is valued at US$ 424.56 Million in 2021, it is projected to reach US$ 599.21 Million by 2028.

    What is the CAGR for Middle East and Africa Veterinary Vaccines Market by (2021 - 2028)?

    As per our report Middle East and Africa Veterinary Vaccines Market, the market size is valued at US$ 424.56 Million in 2021, projecting it to reach US$ 599.21 Million by 2028. This translates to a CAGR of approximately 5.0% during the forecast period.

    What segments are covered in this report?

    The Middle East and Africa Veterinary Vaccines Market report typically cover these key segments-

  • 疫苗类型 (牲畜疫苗, 伴侣动物疫苗)
  • 技术 (减毒活疫苗, 灭活疫苗, 类毒素疫苗, 重组疫苗, 结合疫苗)

    • What is the historic period, base year, and forecast period taken for Middle East and Africa Veterinary Vaccines Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Veterinary Vaccines Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
    • Who are the major players in Middle East and Africa Veterinary Vaccines Market?

    The Middle East and Africa Veterinary Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • BIOVAC
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Elanco
  • Hester Biosciences Limited
  • HIPRA
  • Merck & Co., Inc.
  • NEOGEN Corporation
  • Virbac
  • Zoetis Inc.
    • Who should buy this report?

    The Middle East and Africa Veterinary Vaccines Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East and Africa Veterinary Vaccines Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Request Free Sample Buy Now
    middle-east-and-africa-veterinary-vaccines-market